Search by therapeutic area for drugs approved by the Food and Drug Administration (FDA) for sale in the
United States. Click on an area below to view the complete list of drugs in that category or
review descriptions for our therapeutic
area list to assist you in your search.
FDA Approved Drugs for Pharmacology/Toxicology
Drugs Approved in 2013
Kcentra (Prothrombin Complex Concentrate); CSL Behring;
For the reversal of vitamin K antagonist therapy-induced coagulation factor deficiency, Approved May 2013
Drugs Approved in 2012
Voraxaze (glucarpidase); BTG International;
For the treatment of toxic plasma methotrexate concentrations in patients with impaired renal function, Approved January 2012
Drugs Approved in 2011
Oxecta (oxycodone HCl); Pfizer;
For the management of acute and chronic moderate to severe pain, Approved June 2011
Drugs Approved in 2010
Egrifta (tesamorelin for injection); Theratechnologies;
For the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, Approved November 2010
Zuplenz (ondansetron oral soluble film); Strativa Pharmaceuticals;
For the prevention of post-operative, chemotherapy and radiotherapy induced nausea and vomiting, Approved July 2010
Drugs Approved in 2008
Akten (lidocaine hydrochloride); Akorn;
For anesthesia during ophthalmologic procedures, Approved October 2008
Fusilev (levoleucovorin); Spectrum Pharmaceuticals;
For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate, Approved March of 2008
Sancuso (granisetron); ProStrakan;
For the treatment of chemotherapy-induced nausea and vomiting, Approved September 2008
Drugs Approved in 2004
Campral (acamprosate calcium); Forest Laboratories;
For the treatment of alcohol dependence and the maintenance of alcohol abstinence, Approved August, 2004
Drugs Approved in 2002
Mesnex; Bristol-Myers Squibb, Baxter Healthcare;
Oral tablet to inhibit the hemorrhagic cystitis induced by Ifex (ifosfamide), Approved March 2002
Subutex/Suboxone (buprenorphine/naloxone); Reckitt Benckiser;
Oral tablets for the treatment of opiate dependence, Approved October 2002
Drugs Approved in 1999
Raplon; Organon;
Adjunct to general anesthesia during surgical procedures, Approved August 1999
Drugs Approved in 1997
AneuVysion Assay; Vysis;
Genetic test for birth defects, Approved October 1997
Antizol Injection; Orphan Medical;
Treatment for ethylene glycol poisoning, Approved December 1997
Galzin (zinc acetate); Teva Pharmaceutical;
Treatment for Wilson’s disease, Approved January 1997
Kytril (granisetron) tablets; SmithKline Beecham;
Prevention of nausea and vomiting associated with chemotherapy, Approved November 1997
Omnicef; Warner-Lambert;
Treatment against various bacterias, Approved December 1997
Oxycodone with Acetaminophen 5mg/325mg; Watson Pharmaceuticals;
Generic equivalent of Percocet and Tylox, Approved November 1997
Trovan; Pfizer;
Treatment for bacterial infections, Approved December 1997
Drugs Approved in 1996
Iontocaine; Iomed;
Needle-free anesthetic, Approved May 1996
Lamisil (terbinafine hydrochloride) Tablets; Sandoz Pharmaceuticals;
Treatment for nail fungal infections, Approved May 1996
Nascobal Gel (Cyanocobalamin, USP); Questcor Pharmaceuticals;
Treatment for vitamin B-12 deficiency, Approved November 1996
